Please provide your email address to receive an email when new articles are posted on . A next-generation glucagon analog provided rapid and effective treatment of severe hypoglycemia for children and ...
Researchers have shown that a targeted treatment they developed is effective at controlling blood sugar in patients with hyperinsulinism (HI), a genetic disease in which the pancreas produces too much ...
A marketing authorization for Zegalogue (dasiglucagon, Zealand Pharma) for the treatment of severe hypoglycemia in patients aged 6 years and older with diabetes has been recommended by the European ...
People with diabetes are benefiting from advances in medications and technologies to lower their risk of hypoglycemia, according to a Clinical Practice Guideline issued today by the Endocrine Society.
Hosted on MSN
Type-2 Diabetes: Children under 15 years of age are also vulnerable to diabetes, is your child also a victim of it?
Type-2 diabetes was considered a disease that occurred with aging till a few decades ago, then it gradually started making people under the age of 40 its victims. Many recent studies show that now not ...
CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Data were derived from Ebekozien O, et al. OP 020.
One piece of legislation that could be on the state Legislature’s agenda next year is one that would require health insurers to provide coverage for continuous blood glucose monitors for children.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback